Status:
COMPLETED
Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent)or Travoprost
Lead Sponsor:
Glaukos Corporation
Conditions:
Open-angle Glaucoma
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Evaluation of the intraocular pressure (IOP) lowering effect of two iStent devices versus medical therapy in eyes of subjects with primary open-angle glaucoma, pseudoexfoliative glaucoma, or ocular hy...
Detailed Description
Evaluation of the intraocular pressure (IOP) lowering effect of two iStent devices versus medical therapy in eyes of subjects with primary open-angle glaucoma, pseudoexfoliative glaucoma, or ocular hy...
Eligibility Criteria
Inclusion
- Phakic study eye
- IOP ≥ 21 mmHg and ≤ 40 mmHg at screening exam (OHT requires second screening)
Exclusion
- Aphakic or pseudophakic eyes (AC-IOLs or PC-IOLs)
- Previous usage of topical prostaglandin analogues or prior medical therapy for glaucoma
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2017
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT01443988
Start Date
September 1 2011
End Date
April 1 2017
Last Update
December 18 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
S.V. Malayan Ophthalmological Center
Yerevan, Armenia, 0001